Price Alert

Kronos Bio Inc. (KRON)

NASDAQ: KRON · Real-Time Price · USD

0.88

0.01 (1.49%)

At close: Jun 20, 2025, 9:43 AM

Kronos Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	91.58M	84.57M	74.96M	70.21M	46.2M	64.33M	57.6M	44.4M	61.65M	75.97M	270.34M	86.14M	148.98M	339.51M	216.99M	185.66M	141.45M
Short-Term Investments	8.16M	27.85M	49.89M	66.44M	105.79M	108.67M	129.11M	175.06M	164.76M	162.21M	190.77M	181.75M	154.16M	141.24M	181.39M	231.22M	257.48M
Long-Term Investments	n/a	n/a	n/a	n/a	2.03M	4.01M	11.67M	244K	14.88M	9.76M	12.09M	24.49M	12.25M	2.03M	2.03M	2.38M	41.68M
Other Long-Term Assets	2.14M	2.14M	2.6M	2.6M	577K	577K	3M	3.19M	5.22M	3.19M	2.14M	2.14M	2.14M	112K	112K	2.14M	2.14M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	492K	343K	516K	572K	607K	544K	661K	816K	1.05M	1.22M	1.27M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	-492K	-343K	-15.4M	-10.33M	-12.09M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.14M	2.81M	3.06M	4.54M	6.38M	5.78M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	101.87M	115.23M	127.92M	141.19M	158.36M	178.78M	191.56M	224.12M	232.27M	244.29M	264.63M	274.77M	310.59M	347.55M	402.83M	424.3M	405.27M
Property-Plant & Equipment	4.13M	7M	19.5M	20.48M	22.02M	29.91M	31.76M	33.06M	36.65M	37.69M	38.81M	39.81M	40.88M	41.78M	42.56M	42.92M	38.87M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	6.27M	9.13M	22.11M	23.09M	24.62M	34.5M	46.43M	36.49M	56.76M	50.65M	53.04M	66.45M	55.27M	43.92M	44.7M	47.44M	82.69M
Total Assets	108.14M	124.36M	150.02M	164.27M	182.98M	213.28M	237.99M	260.62M	289.02M	294.94M	317.67M	341.22M	365.86M	391.48M	447.53M	471.74M	487.96M
Account Payables	1.57M	2.4M	1.28M	990K	2.23M	883K	4.08M	2.68M	6.04M	5.05M	1.46M	3.29M	4.72M	998K	3.94M	3.34M	3.59M
Deferred Revenue	n/a	1.86M	5.16M	7.53M	8.67M	9.58M	8.58M	8.82M	8.65M	n/a	n/a	n/a	n/a	9.06M	7.35M	6.52M	4.28M
Short-Term Debt	n/a	3.39M	n/a	3.62M	n/a	2.89M	3.26M	3.04M	3.03M	n/a	2.24M	2.7M	2.5M	n/a	1.73M	1.13M	822K
Other Current Liabilities	148K	7.29M	5.68M	-710K	1.13M	4.42M	2.79M	2.01M	3.23M	1.17M	10.97M	6.97M	6.05M	5.95M	4.58M	2.72M	2.62M
Total Current Liabilities	7.88M	15.28M	15.38M	16.64M	19.03M	24.7M	25.67M	22.05M	25.26M	21.49M	20.11M	18.23M	17.08M	13.63M	14.77M	13.08M	11.29M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	975K	n/a	n/a	n/a	n/a	n/a	87K	209K	350K	490K	795K	1.1M	1.41M	1.71M	2.02M
Total Long-Term Liabilities	20.45M	21.51M	23.51M	24.49M	26.98M	29.51M	33.7M	35.22M	38.16M	28.95M	29.88M	30.75M	31.76M	32.75M	33.73M	34.56M	31.42M
Total Liabilities	28.33M	36.78M	38.9M	41.13M	46.01M	54.2M	59.37M	57.27M	63.42M	50.44M	49.98M	48.98M	48.84M	46.38M	48.51M	47.63M	42.7M
Total Debt	24.09M	24.9M	25.8M	27.13M	27.47M	28.27M	29.54M	30.16M	30.98M	31.09M	31.77M	32.96M	33.47M	33.76M	34.05M	33.98M	30.22M
Common Stock	61K	60K	60K	60K	60K	59K	58K	58K	57K	57K	56K	56K	56K	56K	55K	55K	54K
Retained Earnings	-603.3M	-594.94M	-569.13M	-555.02M	-538.82M	-508.86M	-483.54M	-452.17M	-422.43M	-396.19M	-364.41M	-332.15M	-299.25M	-262.98M	-200.65M	-167.05M	-137.99M
Comprehensive Income	n/a	9K	24K	-36K	-49K	19K	-255K	-469K	-360K	-792K	-1.05M	-661K	-170K	-39K	7K	6K	-23K
Shareholders Equity	79.81M	87.58M	111.13M	123.15M	136.97M	159.08M	178.62M	203.34M	225.6M	244.5M	267.69M	292.24M	317.02M	345.1M	399.02M	424.11M	445.26M
Total Investments	8.16M	27.85M	49.89M	66.44M	107.81M	112.69M	140.78M	175.31M	179.64M	171.97M	202.86M	206.24M	166.4M	141.24M	181.39M	233.6M	299.16M